| 1 | LLY | Eli Lilly and Company | 10.26% |
| 2 | RHHBY | Roche Holding AG | 4.55% |
| 3 | UNH | UnitedHealth Group Incorporated | 4.26% |
| 4 | LON: AZN | AstraZeneca PLC | 4.25% |
| 5 | GILD | Gilead Sciences, Inc. | 3.68% |
| 6 | ABT | Abbott Laboratories | 3.68% |
| 7 | TMO | Thermo Fisher Scientific Inc. | 3.53% |
| 8 | BSX | Boston Scientific Corporation | 3.20% |
| 9 | JNJ | Johnson & Johnson | 3.08% |
| 10 | MDT | Medtronic plc | 3.00% |
| 11 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.99% |
| 12 | ABBV | AbbVie Inc. | 2.97% |
| 13 | SWX: NOVN | Novartis AG | 2.90% |
| 14 | VRTX | Vertex Pharmaceuticals Incorporated | 2.78% |
| 15 | DHR | Danaher Corporation | 2.65% |
| 16 | MRK | Merck & Co., Inc. | 2.53% |
| 17 | CPH: NOVO.B | Novo Nordisk A/S | 2.34% |
| 18 | REGN | Regeneron Pharmaceuticals, Inc. | 2.23% |
| 19 | BBIO | BridgeBio Pharma, Inc. | 2.18% |
| 20 | AMGN | Amgen Inc. | 2.13% |
| 21 | RVMD | Revolution Medicines, Inc. | 2.07% |
| 22 | CYTK | Cytokinetics, Incorporated | 1.84% |
| 23 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.84% |
| 24 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.82% |
| 25 | MCK | McKesson Corporation | 1.79% |
| View HRTS holdings |